Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Inspira Technologies Oxy BHN ( (IINN) ) is now available.
On September 16, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced an increase in the maximum aggregate offering price of its ordinary shares under its Sales Agreement with A.G.P./Alliance Global Partners from $7,117,720 to $9,985,579. This adjustment reflects the company’s strategic move to enhance its financial flexibility and strengthen its market position, potentially impacting its stakeholders positively by providing additional capital for its operations and growth initiatives.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies Oxy B.H.N. Ltd. operates in the medical technology industry, focusing on developing and offering respiratory support technologies. The company is based in Israel and aims to innovate in the field of respiratory care.
Average Trading Volume: 1,148,619
Technical Sentiment Signal: Buy
Current Market Cap: $29.97M
See more insights into IINN stock on TipRanks’ Stock Analysis page.